Senior Analyst
Fransiska Liliani
Fransiska advises leading health companies on understanding and navigating the Indonesian market. She has broad experience mapping Indonesia’s political, regulatory and business landscapes to design and execute strategies aimed at achieving commercial success. Fransiska achieves this while enhancing access to innovative medicines and medical devices and ensuring sustainability in Indonesia’s healthcare financing. Her work includes fostering alliances between businesses, key government officials and non-governmental organizations to advance these policy objectives.
Fransiska is recognized as an expert in healthcare regulation in the Indo-Pacific. She brings broad experience in advocating for public-private partnerships and promoting pro-investment regulations gained through her tenure working in global pharmaceutical companies. Additionally, she possesses a deep understanding of the commercial facets of the healthcare industry, having spearheaded growth and market penetration initiatives for prominent health organizations as a management consultant.
Fransiska holds a master’s degree in biomedical sciences from the University of Tsukuba, Japan. She obtained her pharmacist license from the University of Indonesia, graduating at the top of her class.
Insights & News
Australia to Introduce Age-Based Restrictions for Social Media
The BGA Australia Team led by Managing Director Michael “Mick” McNeill, wrote an update to …
APEC 2024 in Peru: No Flash but Solid Progress
The BGA Indo-Pacific Team’s Senior Adviser Amb. Larry Greenwood wrote a client update on the …
Taiwan’s 2025 Defense Budget Will Increase, but Percent of Overall Spending Drops
The BGA Taiwan Team, led by Senior Adviser Rupert Hammond-Chambers, wrote a client update on …